Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1Phase 3 1Phase 2/3 1

Status

Terminated 2Completed 2Unknown 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 5

Sponsor

Cancer Type

Classical hematology 5Breast 3Other hematologic neoplasm 2

Conditions

Lymphoma 200Leukemia 159Leukemia, Myeloid, Acute 134Precursor Cell Lymphoblastic Leukemia-Lymphoma 132Lymphoma, Non-Hodgkin 111Multiple Myeloma 110Lymphoma, Large B-Cell, Diffuse 108Lymphoma, Follicular 93Hodgkin Disease 91Burkitt Lymphoma 91Myelodysplastic Syndromes 87Lymphoma, Mantle-Cell 87Leukemia, Lymphocytic, Chronic, B-Cell 84Breast Neoplasms 84Lymphoma, Large-Cell, Immunoblastic 73Lymphoma, B-Cell, Marginal Zone 59Sarcoma 54Neoplasms, Plasma Cell 50Neuroblastoma 49Central Nervous System Neoplasms 46Leukemia, Myeloid, Chronic-Phase 43Recurrence 40Ovarian Neoplasms 39Leukemia, Myeloid, Accelerated Phase 39Congenital Abnormalities 39Myeloproliferative Disorders 38Dendritic Cell Sarcoma, Interdigitating 38Blast Crisis 34Leukemia, Myelomonocytic, Chronic 32Neutropenia 29

Interventions

Meropenem 7Vancomycin 6Filgrastim 5Ceftazidime 5pegylated granulocyte colony-stimulating factor 4Cefepime 4pegfilgrastim 3Levofloxacin 3Ciprofloxacin 3Amikacin 3Teicoplanin 2Piperacillin, Tazobactam Drug Combination 2Linezolid 2Interleukin 1 Receptor Antagonist Protein 2Amoxicillin-Potassium Clavulanate Combination 2ceftolozane, tazobactam drug combination 1Vaccination 1Therapeutics 1Tazobactam 1TKN732 1Sodium Chloride 1Simvastatin 1Positron Emission Tomography Computed Tomography 1Pneumococcal Vaccines 1Piperacillin 1Ofloxacin 1NF protocol 1N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid 1Micafungin 1Metronidazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Interventional × Febrile Neutropenia × Filgrastim × Clear all
NCT02685111 2020-07-31

Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC)

Asan Medical Center

Phase 2 Terminated
22 enrolled
BreastClassical hematology

Breast Neoplasms, Neutropenia, Febrile Neutropenia

NCT01569087 2016-12-05

Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast Cancer

Biocad

Phase 2 Completed
60 enrolled 17 charts
BreastClassical hematology

Breast Neoplasms, Neutropenia, Febrile Neutropenia

NCT02104830 2016-10-24

Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer Patients

Biocad

Phase 3 Completed
135 enrolled 18 charts
BreastClassical hematology

Breast Neoplasms, Neutropenia, Febrile Neutropenia

NCT01222819 2016-04-06

G-CSF

Rabin Medical Center

Phase 4 Terminated
120 enrolled
Classical hematologyOther hematologic neoplasm

Leukemia, Febrile Neutropenia

NCT02427919 2015-04-28

DeGREE

Seoul St. Mary's Hospital

Phase 2/3 Unknown
56 enrolled
Classical hematologyOther hematologic neoplasm

Leukemia, Myeloid, Acute, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡